Scientists Troubled: ‘Identical’ Cancer Studies Produce Different Results
January 30, 2017
Get Moving for GI Cancers | BioPlus Specialty Pharmacy
January 31, 2017
Show all

Serum micoRNAs may serve as biomarkers for multiple sclerosis

Small RNA molecules could serves as a biomarker for MS treatment.

MicroRNAs are small RNA molecules that influence basic cellular processes and have been proposed as biomarkers for the diagnosis, progression and treatment of multiple sclerosis. In a new study conducted at the Ann Romney Center of Neurologic Diseases at Brigham and Women’s Hospital, researchers have found that serum microRNAs are linked to MRI findings in the brain and spinal cord in patients with MS. These findings suggest that microRNAs could serve as promising biomarkers for monitoring the progression of MS and could help to identify distinct underlying disease processes, such as inflammation and tissue destruction.

The study was published on January 23, 2017 in JAMA Neurology.

In a large study, researchers examined the connection between serum microRNAs and MRI measures to evaluate the severity of MS, which included looking at lesions and atrophy, a measure of degeneration of the cells, in the central nervous system. Among the findings, the researchers identified that the expression of certain microRNAs were linked to MRI measures. The authors showed that these associations could be protective or harmful to patients (depending upon the function of the microRNA). They also found that different mechanisms were linked to different locations of MS changes, such as in the brain or spinal cord. Additionally, the study suggested certain sets of microRNAs were linked to lesions, while others were linked to atrophy, which is known to cause more devastating effects to MS patients.

Read full article: Serum micoRNAs may serve as biomarkers for multiple sclerosis

Read Full Article: Serum micoRNAs may serve as biomarkers for multiple sclerosis

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.